Health Update

Govt To Set Up Five Mobile Hospitals In India

Govt To Set Up Five Mobile Hospitals In IndiaWith the intention to cater to regions hit by natural or man-made calamities, the government has made announcement about the launching of five mobile hospitals in India that can be established at any calamity hit region within a short span of six hours.

Five mobile hospitals would be established with a total cost of Rs 30 crore each.

Dr. Shakti Gupta, the member of the steering committee of the National Disaster Management Committee (NDMC) under the Home Ministry, took this decision.

“The work is in progress and would be completed soon,” he said.

Healthcare staff motivated to shed extra pounds, to set example for public.

Healthcare staff motivated to shed extra pounds, to set example for public. NHS has understood the value of old maxim, example is better that precept. Department of health is stressing on the importance of fitness of obese NHS staff in lieu with the public messages of reducing weight propagated by them. More than half the NHS's 1.2 million staff is overweight.

Special programs are to be developed for healthcare staff to shed extra pounds. Overweight and obese midwives, health visitors and nurses will be encouraged to enroll in programmes.

Sniffing power of women higher than men

Sniffing power of women higher than men Recent study revealed that women have higher sensitivity towards body odour as compared to men. Research statement indicated that women may be more attuned to biologically relevant information in sweat that may guide them when choosing a mate.

During study, women and men were asked to rate the strength of underarm odours, alone and in combination with various fragrances.

Abdominal obesity increases risk of RLS

Abdominal obesity increases risk of RLS Obesity has been linked to many diseases. Recent study revealed that it also increases risk of developing the neurological disorder, restless legs syndrome (RLS). Nearly one in 10 American adults is affected by RLS.

More data regarding use of asthma drug Symbicort in younger children needed for approval: FDA

FDA The Food and Drug Administration (FDA) has demanded more data from AstraZeneca Plc regarding its asthma drug Symbicort. The company is seeking approval for Symbicort for the long-term maintenance treatment of asthma in 6-11 year-olds.

Symbicort is already approved for patients aged 12 and over. Shares of the company slipped 1 percent after this decision of FDA. It is also approved for treating for chronic obstructive pulmonary disease, or COPD, in adults.

APOE4 gene increases risk of Alzheimer's

APOE4 gene increases risk of Alzheimer's Recent study revealed tha

Pages